Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125.
To the Editor: The authors make an important contribution with their work estimating clinically significant tumor volumes derived from 325 whole mount radical prostatectomy specimens in the first round of the European Randomized Study of Screening for Prostate Cancer. However, we disagree with the conclusions that they draw from the data presented. In fact… (More)